Literature DB >> 12962272

CD4+ T cell matters in tumor immunity.

Markwin P Velders1, Mary A Markiewicz, Gretchen L Eiben, W Martin Kast.   

Abstract

CD4+ T cells have been shown to be able to affect tumor growth through both direct and indirect means. In addition, a requirement has been demonstrated for CD4+ T cells in the regulation and induction of T cell memory, and CD4+ suppressor T cells have been identified, stressing a role for CD4+ T cells in the induction and maintenance of antitumor immune responses. A review of the involvement of CD4+ T cells at different stages of tumor immunity is provided, and based on these data we discuss how CD4+ T cell response induction could be incorporated into tumor immunotherapy strategies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962272     DOI: 10.1080/08830180305220

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  9 in total

1.  Combined influence of adjuvant therapy and interval after surgery on peripheral CD4(+) T lymphocytes in patients with esophageal squamous cell carcinoma.

Authors:  Yang Ling; Lieying Fan; Chunlei Dong; Jing Zhu; Yongping Liu; Yan Ni; Changtai Zhu; Changsong Zhang
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

2.  Effect of Fuzheng Yiliu decoction combined with chemotherapy on patients with intermediate and late stage gastrointestinal cancer.

Authors:  Bin Pan; Tao Cheng; Ke-Jun Nan; Gen-Quan Qiu; Xi-Cai Sun
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

3.  CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.

Authors:  Joel F Aldrich; Devin B Lowe; Michael H Shearer; Richard E Winn; Cynthia A Jumper; Robert K Bright; Ronald C Kennedy
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Effects of a Shuangling Fuzheng anticancer preparation on the proliferation of SGC-7901 cells and immune function in a cyclophosphamide-treated murine model.

Authors:  Hua-Sheng Chen; Jue Chen; De-Li Cui; Yuan-Yuan Zheng; Ai-Hua Xu; Gang Chen; Ling-Chang Jia
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

5.  Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.

Authors:  Saied Mirshahidi; Victor G Kramer; James B Whitney; Sosthène Essono; Sandra Lee; Glenn Dranoff; Karen S Anderson; Ruth M Ruprecht
Journal:  Vaccine       Date:  2009-02-06       Impact factor: 3.641

6.  Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines.

Authors:  Hussain Al Ssadh; Waleed Al Abdulmonem
Journal:  Int J Health Sci (Qassim)       Date:  2019 Mar-Apr

7.  CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.

Authors:  Rajesh K Sharma; Esma S Yolcu; Abhishek K Srivastava; Haval Shirwan
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

8.  Selective cancer-germline gene expression in pediatric brain tumors.

Authors:  Joannes F M Jacobs; Oliver M Grauer; Francis Brasseur; Peter M Hoogerbrugge; Pieter Wesseling; Corrie E Gidding; Mandy W M M van de Rakt; Carl G Figdor; Pierre G Coulie; I Jolanda M de Vries; Gosse J Adema
Journal:  J Neurooncol       Date:  2008-04-09       Impact factor: 4.130

9.  Immunogenicity of targeted lentivectors.

Authors:  Cleo Goyvaerts; De Groeve Kurt; Sandra Van Lint; Carlo Heirman; Jo A Van Ginderachter; Patrick De Baetselier; Geert Raes; Kris Thielemans; Karine Breckpot
Journal:  Oncotarget       Date:  2014-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.